Sammenlign metoder

	Severity of Alcohol Dependence Questionnaire (SADQ)	Brief Addiction Monitor (BAM)	Drug Use Disorders Identification Test (DUDIT)
Fagområde	Afhængighedsmedicin	Afhængighedsmedicin	Afhængighedsmedicin
Familie	Process / pipeline	Process / pipeline	Process / pipeline
Oprindelsesår	1979	2013	2005
Ophavsperson	Stockwell, Murphy, Hodgson	Cacciola, Alterman, Drapkin, Valadez	Berman, Bergman, Palmstierna, Schlyter
Type	Self-report	Self-report	Self-report
Oprindelig kilde	Stockwell, T., Murphy, D., & Hodgson, R. (1983). The Severity of Alcohol Dependence Questionnaire: Its use, reliability and validity. British Journal of Addiction, 78(2), 145–155.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31.
Aliasser	SADQ	BAM	DUDIT
Relaterede	4	4	4
Resumé	The SADQ is a 20-item self-report instrument that measures the severity of alcohol dependence on a continuum from mild to severe. Developed by Stockwell and colleagues in 1979, it quantifies physical withdrawal symptoms, psychological dependence, and behavioral indicators of dependence to guide treatment intensity and medical management decisions. The SADQ remains a widely used assessment tool in addiction medicine and alcohol treatment settings.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings.